Cargando...
Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation
TRAIL-activating therapy is promising in treating various cancers, including pancreatic cancer, a highly malignant neoplasm with poor prognosis. However, many pancreatic cancer cells are resistant to TRAIL-induced apoptosis despite their expression of intact death receptors (DRs). Protein O-GlcNAcyl...
Guardado en:
| Publicado en: | Lab Invest |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183418/ https://ncbi.nlm.nih.gov/pubmed/31896813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41374-019-0365-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|